We maintain our Neutral recommendation on Cepheid following first-quarter 2013 results.
SUNNYVALE, Calif., May 7, 2013 /PRNewswire/ -- Cepheid (NASDAQ: CPHD) today announced that it has appointed Warren C. Kocmond to the position of Executive Vice President, Global Operations, effective May ...
CEPHEID Files SEC form 8-K, Entry into a Material Definitive Agreement, Change in Directors or Principal Officers, FiMay 7
Dexcom's loss shrinks year over year in the first quarter 2013 on higher revenues.
SUNNYVALE, Calif., May 1, 2013 /PRNewswire/ -- Cepheid (NASDAQ: CPHD) today announced that its executives will be speaking at the following conferences, and invited investors to participate via webcast. ...
Amedisys misses Zacks Consensus Estimate in the first quarter of 2013.
ResMed reports a mixed third-quarter fiscal 2013.
FDA Taking More Aggressive Approach in Areas of Totally Unmet Medical Need, Granting Breakthrough Status to New Drugs in Development if No Other Therapeutic OptionWall Street Transcript Apr 26
67 WALL STREET, New York - April 26, 2013 - The Wall Street Transcript has just published its Biotechnology and Pharmaceuticals Report offering a timely review of the sector to serious investors and industry ...